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Submission of manuscripts
A submission letter should always accompany the sub-
mitted paper, providing the following information:
(a) The full name and address of the corresponding
author (including telephone and fax numbers, and e-mail
address).
(b) Any known changes of address within a period of six
months after submission of the paper.
(c) The type of paper
(Regular paper, Rapid report, Short functional sequence-/
Promoter paper or Review) and possibly a preferred section
of the journal for eventual publication.
(d) The full title of the submitted paper.
(e) The names and addresses of 4 - 5 suitable potential
reviewers. If there are compelling reasons for excluding
some individuals as potential reviewers, these can be
mentioned. However, choice of reviewers is at the Editors’
discretion.
Four copies are required of all material submitted,
including the submission letter.
All figures should be provided in quadruplicate and all
four sets of figures should be labelled.
Copies of relevant papers that are submitted elsewhere or
‘in press’, should be provided.
Manuscripts for publication in BBA should be mailed to
one of the Executive Editors via one of the receiving offices.
[Four copies of the hard-copy printout plus the elec-
tronic file of the manuscript.]
Editorial Secretariat
Biochimica et Biophysica Acta
P.O. Box 1345, 1000 BH Amsterdam
The Netherlands
Tel: +31 (20) 485 3510
Fax: +31 (20) 485 3506
E-mail: bba@elsevier.nl
Courier address: Molenwerf 1, 1014 AG Amsterdam,
The Netherlands
Biochimica et Biophysica Acta
Elsevier Inc.
275 Washington Street
Newton, MA 02458
USA
Tel: +1 (617) 630 2244
Fax: +1 (617) 630 2245
E-mail: us_bba@elsevier.com
The Executive Editors are responsible for processing and
professional review of the manuscripts. Authors are free in
their choice of an editorial office, irrespective of their country
of residence.
All materials submitted become the property of BBA.
While manuscripts and figure copies of refused manuscripts
will be returned to the authors whenever possible, this cannot
be guaranteed.
Submission of a manuscript implies that the work
described has not been published before (except in the form
of an abstract or as part of a published lecture or academic
thesis), that it is not under consideration for publication
elsewhere, that its publication has been approved by all the
authors and tacitly or explicitly by the responsible authorities
in the laboratories where the work was carried out and that, if
accepted, it will not be published elsewhere in the same form,
in either the same or another language, without the consent of
the editors and the publisher. Reference should be made to
previously published abstracts, etc. in the introductory sec-
tion. Responsibility for the accuracy of the material in the
manuscript, including bibliographic citations, lies entirely
with the authors.
Ethics
When conducting scientific research using human tissue
and which is intended for publication in BBA, authors should
follow procedures that are in accordance with the ethical
standards as formulated in the Helsinki Declaration of 1975
(revised in 1983). When conducting experiments on animals,
authors should follow the institution’s or the National
Research Council’s guide for the care and use of laboratory
animals.
Revisions and publication dates
Papers requiring revision and/or condensation will be
returned to the authors by the Executive Editors, specifying
the requested alterations and including the (anonymous)
referee reports.
www.bba-direct.com
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Authors are requested to resubmit the revised paper
within 6 months. Papers not resubmitted within six months
will be treated as new submissions.
Proofreading
Authors will receive proofs. Since acceptance is based
upon the submitted version of the paper, it is essential that
no new material be inserted in the text at the time of
proofreading; furthermore, no alteration to style or meaning
will be permitted at this stage. Any new material that the
authors wish to introduce for reasons of scientific accuracy
will be checked by the Executive Editors, and a charge may
be made for corrections. Authors are encouraged to return
their proofs by fax especially in the case of Rapid reports,
Short functional sequence-papers and Promoter papers
where corrections must be faxed or e-mailed to the Publisher
within 48 hours of receipt.
Instructions for authors regarding GenBank/DNA
sequence linking
DNA sequences and GenBank Accession numbers
Many Elsevier journals cite ‘gene accession numbers’ in
their running text and footnotes. Gene accession numbers
refer to genes or DNA sequences about which further
information can be found in the databases at the National
Center for Biotechnical Information (NCBI) at the National
Library of Medicine. Elsevier authors wishing to enable
other scientists to use the accession numbers cited in their
papers via links to these sources, should type this informa-
tion in the following manner:
For each and every accession number cited in an article,
authors should type the accession number in bold, under-
lined text. Letters in the accession number should always be
capitalized. (See Example 1 below). This combination of
letters and format will enable Elseiver’s typesetters to
recognize the relevant texts as accession numbers and add
the required link to GenBank’s sequences.
Example 1: ‘(GenBank accession nos. AI631510,
AI631511, AI632198, and BF223228), a B-cell tumor from
a chronic lymphatic leukemia (GenBank accession no.
BE675048), and a T-cell lymphoma (GeneBank accession
no. AA361117)’.
Authors are encouraged to check accession numbers very
carefully. An error in a letter or number can result in a
dead link.
In the final version of the printed article, the accession
number text will not appear bold or underlined (see Exam-
ple 2 below).
Example 2: ‘GenBank accession nos. AI631510,
AI631511, AI632198, and BF223228), a B-cell tumor from
a chronic lymphatic leukemia (GenBank accession no.
BE675048), and a T-cell lymphoma (GenBank accession
no. AA361117)’.
In the final version of the electronic copy, the accession
number text will be linked to the appropriate source in the
NCBI databases enabling readers to go directly to that
source from the article (see Example 3 below).
Example 3: ‘(GeneBank accession nos. AI631510,
AI631511, AI632198, and BF223228), a B-cell tumor from
a chronic lymphatic leukemia (GenBank accession no.
BE67048), and a T-cell lymphoma (GenBank accession
no. AA361117)’.
Offprints
Twenty-five offprints are provided free of charge.
There are no page charges. An offprint order form, price
list and copyright transfer form are sent upon receipt of the
manuscript at the Publisher so that extra offprints may be
ordered. It is also essential that copyright be transferred at
this stage.
Publication
Information concerning your accepted article can be
obtained by using the ‘‘Track a Paper’’ feature of Elsevier’s
Author Gateway. This will provide you with:
. general production status (in preparation, in proof, in
issue)
. date of publication and offprints dispatch date
. volume, issue and page numbers
Through this site you can also set up e-mail alerts
informing you of changes to your manuscript’s status.
Electronic publishing
Authors are required to submit electronic manuscripts.
Typesetting from computer files has several advantages, not
the least of which is the avoidance of re-keying errors in the
article.
The following points should be taken into account in
preparing electronic manuscripts:
1. Files produced by most commercial wordprocessing
software packages (but preferably WordPerfect) can be used
directly by the publisher. Save your files as usual on a
floppy disk (the preferred storage medium is a 5.25- or a
3.5-inch disk in the MS-DOS (or compatible) system).
Apple Macintosh or NEC is also suitable; if you use
NEC, please submit your article on a double density or
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high density 5.25 inch disk or double density 3.5 inch disk
(not a high density 3.5 inch disk). For other systems please
contact the BBA Editorial Secretariat first. Please do not
save your text as ASCII or similar: this will cause all special
formatting codes to be lost.
2. Authors should not use (or allow their word processor
to introduce) any hyphenation or word splits and they
should not use a ‘justified’ layout.
3. Authors should ensure that the digit ‘1’ and the letter
‘l’ (also the digit ’0‘ (zero) and the capital letter ‘O’) have
been used properly. The letter X and the ‘times’ sign, the
apostrophe and the prime, and the hyphen and dash (for
minus, etc.) represent further sources of confusion.
4. If the word processor or printer has any special
characters, e.g., a¨, h, eˆ, ø, Greek letters and mathematical
symbols, they should be used consistently throughout the
text.
5. Non-reproducible characters should not be left as
blank spaces in the file, but should be replaced by characters
or codes not used elsewhere, and should be used consis-
tently, e.g., sigma, cap for j, and sigma, l.c. for B. A list of
such characters (codes) and a lexicon of what they actually
represent should be added as a separate file on the disk.
6. All instructions given on style and arrangement of
Regular papers should also be followed when preparing
electronic manuscripts. This is especially important for the
References section. Consistency in all operations is of vital
importance in the preparation of articles. Facilities for
‘automatic’ numbering of references and footnotes must
not be used.
7. In any case of doubt, authors are welcome to contact
the publisher before keying in an article.
The following points should be taken into account in
submitting electronic manuscripts:
1. The file must contain the final corrected version of the
article and must match exactly the accompanying hard-copy
printout — the final (revised) manuscript.
2. The output from specific desk-top publishing (DTP)
equipment includes a considerable amount of coding which
will interfere with normal file processing. Such DTP output
should therefore be avoided.
3. Four copies are required of the hard-copy printout.
4. Figures and tables are also handled electronically.
5. The disk should be labelled with: - the name of the
author who will receive the proofs — the manuscript
reference number (when known) — the soft- and hardware
used — the names of the files.
6. The disk and the four copies of the hard-copy
printout should be accompanied by a submission letter
(see above).
7. Any revised version of a manuscript should be
accompanied by a new set of figures and a disk contain-
ing the final revised version of the paper.
BBA’s publications
BBA publishes English-language papers only. Papers
may be written in either American or British English,
provided that the preferred spelling is used consistently
throughout.
Many readers of the journal are not native speakers of
English. It is therefore important to write succinctly and
clearly, using short, simple sentences and avoiding long
adjectival phrases and laboratory jargon. The following
types of paper are published:
Regular papers
A Regular paper is the normal medium of publication.
Although there is no fixed length, Regular papers should be
as concise as possible, while providing sufficient informa-
tion for the work to be repeated and for the claims of the
authors to be judged by the readers.
Rapid reports
Rapid reports should meet the following conditions:
(1) encompass a complete piece of work of special
significance and timeliness;
(2) be concise and not normally exceeding 4 printed
pages (i.e., up to 12 pages of double spaced typescript,
including tables and figures up to a total number of 4);
(3) comprise no separate sections, except for a summary
and the reference list.
(4) should preferably be sent by e-mail in pdf format to
one of the receiving offices; bba@elsevier.nl (Amsterdam,
The Netherlands), or us_bba@elsevier.com (Newton, MA,
USA.
Authors should note that:
(a) Submission of a Rapid report should be accompanied
by a letter briefly describing why the author believes his
paper to be deserving of rapid publication. Failure to
provide this information can lead to delays in the manuscript
handling.
(b) An e-mail address or fax number must be given to
enable turnaround of corrected proofs within 48 h.
(c) Rapid reports will be added to the beginning of issues
currently in production.
(d) An accepted Rapid report will generally be published
within 8 weeks of the date of receipt at the Publisher’s
office, depending on issue scheduling.
Short functional sequence-/Promoter papers
These are mainly published in the ‘Gene Structure and
Expression’ section, and conform in style and format to
BBA Rapid reports. Short functional sequence-papers
should provide information on the function of the gene
and include a comparison of related sequences, a descrip-
tion of salient features of the sequence and significant
experimental data on function and expression of the
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genes described. Papers presenting sequences presumably
coding for a protein must be accompanied by sufficient
evidence, e.g. expression data, that the gene indeed codes
for such a protein. If the paper only confirms in one
organism what is already known for several other species,
or describes sequences without information on the func-
tion, it will not be considered eligible for publication in
BBA. If the cDNA sequence has been published before,
BBA will not consider manuscripts describing the
sequence of the gene unless accompanied by functional
studies on the promoter, as in Promoter papers, or other
functional data related to the genomic organization and
expression. Promoter papers include data on promoter or
enhancer sequences or other regulatory regions required
for gene expression. In addition to the sequence itself,
these papers should include novel information on the
transcription start site and functional studies, e.g., using
reporter genes. Such studies could entail a deletion
analysis or otherwise establish functional regions in the
promoter that act either positively or negatively. In
addition, information on the recognition of these func-
tional regions by transcription factors could be included,
e.g., using band shifts or footprints.
Manuscripts should be marked ‘Short functional
sequence-/Promoter paper’ and the accompanying submis-
sion letter should state explicitly that a Short functional
sequence-/Promoter paper is being submitted.
Sequences should be deposited in one of the usual data
banks before submission. Accession numbers should be
mentioned in the submission letter and in a footnote to the
Short functional sequence-/Promoter paper. In general
accession numbers suffice. Only in exceptional cases should
the sequence be presented as a figure.
Short crystallization papers
These are published in the BBA section on Protein
Structure and Molecular Enzymology and conform in style
and format to BBA Rapid reports. These short reports are
intended for the description of the crystallization of pro-
teins for X-ray analysis. They should offer information on
the protein studied. The protein should be of biochemical-
biological importance and not highly homologous to pro-
teins of known structures, unless there is a particular
reason why this might be interesting. Unit cell demensions
and spacegroup determination and an estimate of the
resolution that can be obtained should be provided. Cor-
rection of proofs follows that of other rapid publication
papers.
Reviews
BBA reviews are published in the independent section
Reviews on Cancer and in all other sections of the journal.
They are contributed by scientists who are leading special-
ists in their field of expertise, normally at the invitation of
the Executive Editors. Authors wishing to contribute a
review paper are advised first to contact one of the
responsible Executive Editors (listed in the issues of
BBA) to avoid overlap with Reviews already commis-
sioned.
Preparation of papers
Authors should consult a recent issue of the journal to
make themselves familiar with the conventions and layout
of articles.
The entire text, including figure and table legends and the
reference list, should be typed (or printed out) with double
or triple spacing on one side of the paper, leaving a left
margin of approx. 3 cm. All pages should be numbered
consecutively, starting with the title page of the manuscript.
Every new paragraph should be clearly indented. Hand-
written characters should be clearly defined in the margin.
Expressions of Latin origin, for example, in vivo, in vitro, et
al., perse should be typed in normal typeface. They should
be neither italicized nor underlined.
Equations should be numbered in the right margin as
follows:
A+B !C+D(1)
Title page
The title should be concise, descriptive and informative.
The names of the authors should be followed by their
addresses and indicated by corresponding letters. Changes
in address should be indicated by footnotes. The author(s) to
whom correspondence and proofs should be sent should be
indicated, giving a full address (including fax number and e-
mail address).
Authors are requested to select a maximum of six key
words and to present them on the title page of the typescript.
These key words will be used in the compilation of the
annual cumulative index. They should cover precisely the
contents of the submitted paper and should give readers
sufficient information as to the relevance of the paper to his/
her particular field.
Summary
The second page of the typescript should be reserved for
the Summary. This should be self-explanatory and intelli-
gible without reference to the body of the paper.
A Regular paper should have a Summary of 100–200
words; Rapid reports and Short functional sequence-papers
should have summaries of approximately 50 words.
Since summaries are increasingly used by abstracting
services which will cut off after a fixed number of words, it
is important not to exceed the maximum number of words
and to avoid bibliographic references and non-standard
abbreviations.
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Regular papers
After the Summary, Regular papers are usually divided
into the sections Introduction, Materials and methods,
Results, Discussion and Acknowledgements.
Introduction
This is a short section in which the authors should state
the reasons for performing the work, with brief reference to
relevant previous work.
Materials and methods, Results, Discussion
The section Materials and methods should be detailed
enough for readers to reproduce the experiments. Authors
should always refer to other work on the same subject,
indicating whether or not their experimental results are in
agreement with previous work. Conclusions drawn from
experiments described in the tables or figures can often
appear most conveniently in the Results section. The overall
conclusions based on the work reported should be given in
the Discussion. In shorter papers the Results and Discussion
sections may be combined.
Acknowledgements
Acknowledgements should be presented at the end of the
main text in a separate section.
Rapid reports, Short crystallization-, Short functional
sequence- and Promoter papers
These types of paper are not divided into sections after
the summary, except for the reference list. The first para-
graph serves as an introduction; acknowledgements are
added as a final paragraph before the reference list.
References and citations
The numerical system of references should be used.
References in the text should be cited by numbers in square
brackets in the order of their citation.
References are listed together in their order of appearance
in a separate section at the end of the text under the heading
References. All references should be numbered consecu-
tively. References to journals should contain initials and
names of all authors, article title, abbreviation of the name
of the journal according to the List of Serial Title World
Abbreviations (International Series Data System, 20, rue
Bachaumont, 75002 Paris, France. ISBN 2-904938-02-8),
volume number, year of publication (between brackets), and
page numbers. References to books should also include the
title (of series and volumes), initials and names of the
editor(s), the publisher and place of publication.
Examples
[1] M. Wikstro¨m, J.E. Morgan, M.I. Verkhovsky, Proton
and electrical charge translocation by cytochrome-c oxidase,
Biochim. Biophys. Acta 1318 (1997) 299–306.
[2] E.C. Slater, Biochimica et Biophysica Acta: The Story
of a Biochemical Journal, Elsevier Science Publishers,
Amsterdam, 1986.
[3] D.E. Vance, Glycerolipid biosynthesis in eukaryotes,
in: D.E. Vance, J.E. Vance (Eds.), New Comprehensive
Biochemistry, vol. 31, Biochemistry of Lipids, Lipoproteins
and Membranes, Elsevier Science B.V., Amsterdam, 1996,
pp. 153–181.
Reference to a paper as ‘in press’ implies that it has been
accepted for publication. Evidence (e.g., a photocopy of the
note of acceptance from the journal concerned) should
accompany the submitted typescript. Papers that are ‘in press’
should be included as a number in the text. Other papers
submitted before or simultaneously with the paper in question
should be included as a number in the text and in the
References section, stating the name of the journal. Copies
of papers that are submitted elsewhere should be provided for
inspection by the Editors. Omission of this information will
delay publication and may lead to redating of a submitted
manuscript. Papers presented at scientific meetings that are
not available in published form should not be cited as
references in the References section.
Unpublished results should not be listed in the References
section. In the text they are mentioned as follows: ‘‘(Tervoort,
M.V. and Glimcher, J., unpublished data)’’. When unpub-
lished results are cited, the data should be provided for the
Editors’ information when essential for proper evaluation, or
if requested.
A personal communication should be mentioned in the
text as follows: ‘‘(Tervoort, M.V., personal communica-
tion)’’. Authors should not make unauthorized use of per-
sonal communications. Personal communications are not to
be included in the References section.
Tables
Tables should be used sparingly; they should be used only
when the data cannot be presented clearly in the text. Authors
are requested to consult recent issues of BBA for the proper
table layout.
Each table, including its legend, should be typed on a
separate page. The heading of the table should make its
general meaning understandable without reference to the
text.
Figures and illustrations
Figures should be used to illustrate experimental results
clearly. As figures are often reduced to a one-column width,
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authors should bear in mind the size of BBA’s printed page
and they should ensure that symbols, lettering and lines are
sufficiently large and clear to be legible after reduction.
(Column width is 8.4 cm, preferred figure size is approx-
imately double this).
Legends should be collated and typed with double or
triple spacing on a separate sheet. A legend should consist
of an opening sentence constituting a brief title (without
extra capitalization), followed by a brief description of the
figure.
All figures should be in a form suitable for reproduction,
e.g., drawn in black, on waterproof drawing or tracing
paper, or as sharp, glossy prints. Each figure should bear
the figure number, the name of the corresponding author and
the (shortened) title of the paper on the reverse side. Figures
should never be folded and they should never be mounted
on heavy card. Continuous or half-tone figures should have
their labelling supplied as an overlay, or be supplied in
duplicate.
The size of symbols in relation to lettering should be
chosen carefully.Photographs of gels, micrographs, etc.,
should be glossy and as rich in contrast as possible. For
photographs of electrophoretic patterns and electron micro-
graphs four high-quality prints must be provided. If the
content of a photograph is likely to suffer as a result of
reduction, it should be provided in a size that will fit within
BBA’s format without reduction (preferred size is 8.4
cm11 cm). In the case of electron micrographs, unit length
must be indicated on the figure by a labelled bar.
Submit colour illustrations as original photographs, high-
quality computer prints or transparencies, close to the size
expected in publication, or as 35 mm slides. Polaroid colour
prints are not suitable. If, together with your accepted
article, you submit usable colour figures then Elsevier will
ensure, at no additional charge, that these figures will appear
in colour on the web (e.g., ScienceDirect and other sites)
regardless of whether or not these illustrations are repro-
duced in colour in the printed version. For colour repro-
duction in print, you will receive information regarding the
costs from Elsevier after receipt of your accepted article. For
further information on the preparation of electronic artwork,
please see http://authors.elsevier.com/artwork.
Please note: Because of technical complications which
can arise by converting colour figures to ‘grey scale’ (for the
printed version should you not opt for colour in print) please
submit in addition, usable black and white prints corre-
sponding to all the colour illustrations.
When essential to the understanding of a paper, figures
may be reproduced in colour, at the author’s own expense.
The price of a single printed full-colour page is EUR 340,-
exclusive of sales tax. Two, three or four full-colour pages
in combination will cost EUR 227,- per additional page
excluding sales tax. Authors should take into consideration
that color illustrations reproduced from a slide provide a
better-quality, clearer result than those reproduced from a
photograph.
Preparation of supplementary data. Elsevier now accepts
electronic supplementary material to support and enhance
your scientific research. Supplementary files offer the author
additional possibilities to publish supporting applications,
movies, animation sequences, high-resolution images,
background datasets, sound clips and more. Supplementary
files supplied will be published online alongside the elec-
tronic version of your article in Elsevier web products,
including ScienceDirect: http://www.sciencedirect.com. In
order to ensure that your submitted material is directly
usable, please ensure that data is provided in one of our
recommended file formats. Authors should submit the mate-
rial in electronic format together with the article and supply a
concise and descriptive caption for each file. For more
detailed instructions please visit our Author Gateway at
http://authors.elsevier.com.
Files can be stored on 3 1/2 inch diskette, ZIP-disk or CD
(either MS-DOS or Macintosh).
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